Inoue K, Okamura T, Fukushima S, Ito N, Ohtaguro K
Gan To Kagaku Ryoho. 1987 Jan;14(1):71-6.
The effects of intravesical instillation of cytosine arabinoside (CA), mitomycin C (MMC) and combination of CA and MMC were examined in rats pretreated with N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN). Rats were given initial treatment with BBN for 4 weeks followed by intravesical instillation of drugs once a week for 12 weeks. The total observation period was 36 weeks. Instillation of MMC markedly increased the development of bladder tumors, although CA did not. Moreover, tumor incidence in the combination group was less than that with MMC only. The results indicate that the intravesical instillation of MMC promotes 2-stage bladder carcinogenesis, whereas CA does not. Moreover, it is suggested that CA inhibits the promoting effect of MMC.
在经N-丁基-N-(4-羟基丁基)-亚硝胺(BBN)预处理的大鼠中,研究了膀胱内灌注阿糖胞苷(CA)、丝裂霉素C(MMC)以及CA与MMC联合用药的效果。大鼠先用BBN治疗4周,随后每周进行一次膀胱内药物灌注,持续12周。总观察期为36周。灌注MMC显著增加了膀胱肿瘤的发生,而CA则没有。此外,联合用药组的肿瘤发生率低于单独使用MMC组。结果表明,膀胱内灌注MMC可促进二阶段膀胱致癌作用,而CA则不能。此外,提示CA可抑制MMC的促进作用。